PDP
PDP
Skip to content Skip to navigation menu
Your browser is not supported by this site.
Please update to the latest version, or use a different browser for the best experience.
Generic Pharmaceutical Patent and FDA Law, 2020 ed.

Product details:

Format: Book - softbound
Brand: Thomson West
Copyright: 2020
ISBN: 9781539234043
Service #: 40614278
Sub #: 40614279
Pages: 1402
Shelf Space: 2 in.
Publication Frequency: Updated annually
Update format: Replacement pamphlets

Can we help?

Contact Us 
Call 1-888-728-7677

Generic Pharmaceutical Patent and FDA Law, 2020 ed.

106660975

Availability:

In stock
(details)

106660975
106660975
One time purchase
$787.00
Purchase the current version only, no updates will be sent.


Monthly pricing
$60.00/month
Our Assured Print Pricing program offers predictable monthly pricing and capped year-over-year price increases. Choose between 2, 3, 5, and 10-year agreements. All updates, new editions, and revisions are included in your monthly payment and delivered automatically, as soon as they become available.


Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration (FDA)approval of generic drugs and the interaction of patents and FDA law. A practitioner's guide, it walks the reader through the stages of drug approval, identifying the critical issues in the process and advising the client about the issues and areas of concern or exploitation. It also discusses the areas that impact the interaction of patents and Food and Drug Administration law, including litigation. Features of this publication include:

  • Provides step-by-step process for understanding, strategizing, and litigating generic drug patent infringement
  • Provides comprehensive background in patent and (FDA) regulatory law, integrating them into one cohesive bundle
  • Dissects each complex issue into its parts and cross-references it to other issues
  • Provides an excellent teaching tool for associates, partners, law clerks, judges, and financial managers
  • Provides case studies, illustrations, and timelines
  • Covers the generic drug industry exclusively, blending generic drug patent and FDA issues
  • Offers citations to cases